ahlam1399
05-28-2015, 07:25 PM
UPDATE 1-U.S. settles ?pay for delay? fight with drugmaker Cephalon
WASHINGTON, May 28 (Reuters) - U.S. antitrust regulators have settled a long-running fight with Cephalon, **w owned by Teva Pharmaceuticals, over how it resolved a patent infringement lawsuit tied to wakefulness drug Provigil, the Federal Trade Commission said on Thursday.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46b98b02/sc/7/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/1/rc.img (http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/1/rc.htm)
http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/2/rc.img (http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/2/rc.htm)
http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/3/rc.img (http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/3/rc.htm)
http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/a2.img (http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/a2.htm)
http://adchoice.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/ach.img (http://adchoice.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/ach.htm)http://pi.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/a2t.imghttp://pi2.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=chM1xd2Pso8:eyqetpXOK9Y:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=chM1xd2Pso8:eyqetpXOK9Y:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=chM1xd2Pso8:eyqetpXOK9Y:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=chM1xd2Pso8:eyqetpXOK9Y:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=chM1xd2Pso8:eyqetpXOK9Y:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/chM1xd2Pso8
WASHINGTON, May 28 (Reuters) - U.S. antitrust regulators have settled a long-running fight with Cephalon, **w owned by Teva Pharmaceuticals, over how it resolved a patent infringement lawsuit tied to wakefulness drug Provigil, the Federal Trade Commission said on Thursday.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46b98b02/sc/7/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/1/rc.img (http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/1/rc.htm)
http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/2/rc.img (http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/2/rc.htm)
http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/3/rc.img (http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/rc/3/rc.htm)
http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/a2.img (http://da.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/a2.htm)
http://adchoice.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/ach.img (http://adchoice.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/ach.htm)http://pi.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/a2t.imghttp://pi2.feedsportal.com/r/228858249268/u/49/f/654213/c/35217/s/46b98b02/sc/7/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=chM1xd2Pso8:eyqetpXOK9Y:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=chM1xd2Pso8:eyqetpXOK9Y:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=chM1xd2Pso8:eyqetpXOK9Y:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=chM1xd2Pso8:eyqetpXOK9Y:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=chM1xd2Pso8:eyqetpXOK9Y:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/chM1xd2Pso8